Cincinnati Enquirer: 'Don't panic.' Anti-diabetes medication recalled, may contain high levels of cancer-causing compound
UC diabetes experts offers advice for patients in wake of recall
Two pharmaceutical companies issued voluntary recalls Monday for metformin, an anti-diabetes drug, due to high levels of a cancer-causing compound, according to the U.S. Food and Drug Administration. Metformin is used to treat type 2 diabetes, according to Mayo Clinic, and is distributed under the following brand names: Fortamet, Glucophage, Glucophage XR, Glumetza and Riomet.
The Cincinnati Enquirer spoke with Dr. Shailendra Patel, a professor and director of the UC Division of Endocrinology, Diabetes and Metabolism and UC Health physician, about the recall. He offered a message for patients who use metformin: do not quite the drug cold turkey.
"Don't panic," Patel told the Enquirer. "Just have a nice discussion with your provider. And make sure that if the medication's the only thing that's controlling your disease, don't stop it. Just go in and ask and say, 'what are my alternatives?' "
Read the full story in the Cincinnati Enquirer.
Learn more about Dr. Shailendra Patel.
Featured photo of blood sugar management device and generic medication courtesy of Unsplash.
Related Stories
UC doctoral student shares his journey with Spectrum News
July 27, 2026
UC doctoral student Amota Ataneka spoke with Spectrum News about his educational journey. Ataneka, a native of the Pacific island nation of Kiribati, is one of 35 emerging scholars across the United States to win the National Academy of Education/Spencer Dissertation Fellowship.
How scammers can persuade you with AI
July 27, 2026
Spectrum News recently dove into how cloning voices with artificial intelligence is making it easier to scam people over the phone. The news outlet spoke with Kimberly Hyun, assistant professor of marketing at UC’s Lindner College of Business, to examine why AI is making it so much easier to trick people.
Decade of discovery
July 27, 2026
Every summer, UHP Discover has connected undergraduate students in the University Honors Program (UHP) to a unique array of opportunities in original interdisciplinary research. This year, the program celebrates its 10th anniversary.